Nanexa

Nanexa EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Nanexa (NANEXA.ST) as of Oct 16, 2026 is -367.17. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -21.66 — a change of 1,594.82% (lower).

EV/OCF

-367.17

YoY

1,594.82%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Nanexa is 2025 -367.17 . EV/OCF (Enterprise Value to Operating Cash Flow) of Nanexa was 2024 -21.66 . It decreases by 1,594.82% lower compared to the previous year.

The Nanexa EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
-84.99 SEK
Jan 1, 2019
-60.84 SEK
Jan 1, 2020
-33.90 SEK
Jan 1, 2021
-19.00 SEK
Jan 1, 2022
-64.07 SEK
Jan 1, 2023
-12.14 SEK
Jan 1, 2024
-21.66 SEK
Jan 1, 2025
-367.17 SEK
The Nanexa EV/OCF history
YEAREV/OCFYoY
-367.17+1,594.82%
-21.66+78.40%
-12.14-81.04%
-64.07+237.25%
-19.00-43.96%
-33.90-44.29%
-60.84-28.41%
-84.99-23.14%
-110.58+24.74%
-88.65-49.33%
-174.97-117.03%
1,027.52—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nanexa Stock analysis

What does Nanexa do? Nanexa AB is a company based in Uppsala, Sweden, operating within the Health Care sector. The company went public on June 17, 2015, with its ticker listed as NANEXA.ST and ISIN SE0007074166. Nanexa AB focuses on the development, production, and distribution of medical nanotechnology products. The company's product portfolio includes PharmaShell, a drug delivery system designed for targeted drug administration and precise dosing. Additionally, it offers an antifungal coating system that prevents fungal growth on medical devices, and a low-friction coating for peripheral venous catheters. The company is engaged in nanotechnology and research and development within the life sciences field. Nanexa AB's headquarters are located in Uppsala, Sweden, and it maintains a website at nanexa.com for further information. The company's activities are centered around innovative medical solutions leveraging nanotechnology to address specific challenges in healthcare applications. Nanexa is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nanexa stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Nanexa is -367.17 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Nanexa changed from -21.66 to -367.17, representing a 1,594.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Nanexa since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Nanexa with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Nanexa

All Key Metrics — Nanexa